Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Abbas Kebriaeezadeh"'
Autor:
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh
Publikováno v:
Complexity, Vol 2024 (2024)
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system. This paper presents a framework for evaluating the SC risks of Iranian bi
Externí odkaz:
https://doaj.org/article/8ef54d10003741519b10ad59fbbf1789
Autor:
Abolfazl Sadeghi, Yahya Bayazidi, Majid Davari, Abbas Kebriaeezadeh, Amin Assarian, Alireza Esteghamati, Sepideh Yousefi
Publikováno v:
Iranian Journal of Medical Sciences, Vol 48, Iss 3, Pp 286-291 (2023)
Background: Clinical guidelines and expert committees have recently suggested that the hemoglobin A1C (HbA1c) should be individualized based on various criteria. Data regarding the achievement of individualized glycemic targets in type 2 diabetes mel
Externí odkaz:
https://doaj.org/article/5a4849b5f5204306a75bbedd543afc4e
Autor:
Rahill Sadat Shahtaheri, Yahya Bayazidi, Majid Davari, Abbas Kebriaeezadeh, Sepideh Yousefi, Alireza Mahdavi Hezaveh, Abolfazl Sadeghi, Ahmed Hayder Mohsin aL Lami, Hadi Abbasian
Publikováno v:
Health Economics Review, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Background The quality of health care has a significant impact on both patients and the health system in terms of long-term costs and health consequences. This study focuses on determining the long-term cost-effectiveness in quality of diabe
Externí odkaz:
https://doaj.org/article/a6b9dd9e7e454637a61fdddffc21ce3d
Autor:
Majid Davari, Yahya Bayazidi, Abbas Kebriaeezadeh, Alireza Esteghamati, Fatemeh Bandarian, Zahra Kashi, Adele Bahar, Sepideh Yousefi
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Appropriate service delivery, access to high quality of cares and optimal management of type 2 diabetes mellitus (T2DM) can decrease the risk of micro and macro vascular complications and mortality. Therefore, monitoring the quali
Externí odkaz:
https://doaj.org/article/23c8e6a2f0494a2b9dbc95b5c516518f
Autor:
Nayyereh Ayati, Monireh Afzali, Mandana Hasanzad, Abbas Kebriaeezadeh, Ali Rajabzadeh Ghatari, Shekoufeh Nikfar
Publikováno v:
Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān, Vol 24, Iss 2, Pp 245-254 (2022)
Introduction: Pharmacogenomics may well have substantial effects on the clinical, economic and regulatory aspects of health sector; which can lead to complications in access. Therefore, there is a need for evidence-based frameworks based on national
Externí odkaz:
https://doaj.org/article/30cdccca814b450a8fcd34022e85f240
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 8, Iss 4 (2023)
Background: Coronavirus (COVID-19) pandemic has caused great shocks across all sectors of society. The pandemic highlighted three crucial policy issues (i.e., healthcare spending, social determinants of health, and health equity). It is also projecte
Externí odkaz:
https://doaj.org/article/c2f266f71ff74a3bb62e7bac33fb042b
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 8, Iss 3 (2023)
Background: Initial combination therapy, preferentially fixed-dose combination (FDC) therapy is recommended by most of the clinical guidelines for the management of hypertension in adults. However, there is inadequate evidence on the impact of FDC on
Externí odkaz:
https://doaj.org/article/eeebe865027a4672ad1eca188add1985
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 8, Iss 3 (2023)
Background: A comprehensive ecosystem for hypertension care is needed, particularly in Sub-Saharan Africa (SSA), to address disproportionately increasing hypertension prevalence and poor blood pressure (BP) control. Therefore, this explanatory review
Externí odkaz:
https://doaj.org/article/46aa9c41ba5a45b9a806b0da1601c02d
Autor:
Hadi Abbasian, Reza Yousefi-Zenouz, Akbar Abdollahiasl, Mahdi Toroski, Shekoufeh Nikfar, Mohammadreza Siahi-Shadbad, Abbas Kebriaeezadeh
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 3, Pp 439-449 (2021)
Background: Supply chain risk management can help companies detect potential hazards,mitigate potential risks, and thereby increase supply chain efficiency. The biopharmaceuticalindustry in Iran has a generic-based pharmerging market. Therefore, iden
Externí odkaz:
https://doaj.org/article/aa6ca241445d497fb3950cfaf91a8edc
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/1a2a72d534714b08bb572d28f2504668